Integral Diagnostics Limited (IDX.AX)
AUD 2.9
(-2.68%)
AUD 2.9
(-2.68%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 12.33 Million AUD | -86.7% |
| 2023 | 92.74 Million AUD | 11.28% |
| 2022 | 69.9 Million AUD | -9.23% |
| 2021 | 88.93 Million AUD | 29.18% |
| 2020 | 69.49 Million AUD | 24.72% |
| 2019 | 50.32 Million AUD | 34.96% |
| 2018 | 34.5 Million AUD | 13.59% |
| 2017 | 33.98 Million AUD | -4.85% |
| 2016 | 28.5 Million AUD | 4.6% |
| 2015 | 33.67 Million AUD | 867.61% |
| 2014 | 3.48 Million AUD | 2522106.52% |
| 2013 | 138.00 AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 43.13 Million AUD | -171.16% |
| 2024 Q4 | 46.75 Million AUD | 239.23% |
| 2024 FY | - AUD | 6.44% |
| 2023 Q2 | 39.27 Million AUD | 6.69% |
| 2023 FY | - AUD | 11.28% |
| 2023 Q4 | 44.78 Million AUD | 14.02% |
| 2022 Q2 | 38.51 Million AUD | -1.95% |
| 2022 FY | - AUD | -9.23% |
| 2022 Q4 | 36.81 Million AUD | -4.42% |
| 2021 Q2 | 49.81 Million AUD | 27.75% |
| 2021 Q4 | 39.27 Million AUD | -21.16% |
| 2021 FY | - AUD | 29.18% |
| 2020 FY | - AUD | 24.72% |
| 2020 Q4 | 38.99 Million AUD | 17.36% |
| 2020 Q2 | 33.22 Million AUD | 33.49% |
| 2019 Q4 | 24.89 Million AUD | -5.33% |
| 2019 FY | - AUD | 34.96% |
| 2019 Q2 | 26.29 Million AUD | 37.48% |
| 2018 Q4 | 19.12 Million AUD | 0.93% |
| 2018 Q2 | 18.94 Million AUD | 13.75% |
| 2018 FY | - AUD | 13.59% |
| 2017 Q4 | 16.65 Million AUD | -1.2% |
| 2017 FY | - AUD | -4.85% |
| 2017 Q2 | 16.86 Million AUD | -8.2% |
| 2016 Q4 | 18.36 Million AUD | 8.93% |
| 2016 Q2 | 16.86 Million AUD | -5.54% |
| 2016 FY | - AUD | 4.6% |
| 2015 Q4 | 17.84 Million AUD | 12.75% |
| 2015 FY | - AUD | 867.61% |
| 2015 Q2 | 15.83 Million AUD | 0.0% |
| 2014 FY | - AUD | 2522106.52% |
| 2013 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Australian Clinical Labs Limited | 181.83 Million AUD | 93.217% |
| BCAL Diagnostics Limited | -5.66 Million AUD | 317.653% |
| Genetic Signatures Limited | -20.33 Million AUD | 160.645% |
| Genetic Technologies Limited | -11.43 Million AUD | 207.902% |
| Healius Limited | -298.09 Million AUD | 104.138% |
| Imagion Biosystems Limited | -13.69 Million AUD | 190.05% |
| INOVIQ Ltd | -6.63 Million AUD | 285.938% |
| Microba Life Sciences Limited | -22.8 Million AUD | 154.075% |
| Monash IVF Group Limited | 13.02 Million AUD | 5.305% |
| Rhythm Biosciences Limited | -6.79 Million AUD | 281.492% |
| Sonic Healthcare Limited | 1.65 Billion AUD | 99.257% |